MRI for DES
This article was originally published in The Gray Sheet
Executive Summary
FDA clears labeling for drug-eluting stents allowing a magnetic resonance imaging exam immediately following implant. The agency approved the claim for Boston Scientific's Taxus paclitaxel-eluting stent and J&J/Cordis' Cypher sirolimus-eluting stent on April 5 and April 20, respectively, based on lab studies. Previously, DES labeling advised waiting two months before an MRI exam for fear that the magnetism would cause the stent to heat or migrate...